We applied the novel P2X7R inhibitor A‐740003 and the IL‐1R inhibitor Anakinra to explore the role of P2X7R and IL‐1β in the pathogenesis of MI as described in Protocol 3, 16, 30, 31, 32, 33. Here, IL1R1 is linked to myocardial infarction.